Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc. (BSPM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bspm · pe ratio · data through Dec 31, 2016
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Biostar Pharmaceuticals, Inc. (BSPM) measures how much investors pay for each dollar of the company's trailing earnings. BSPM's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$2.48.
Source: FMP · /ratios-ttm · /analyst-estimates · 2016-12-31
PE Ratio History
2006 – 2016 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%19.6x
MedianQ3 · 75%143.2x
Max
At N/A, BSPM's current P/E is lower than in 0% of its annual fiscal year readings over the past 8 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Biostar Pharmaceuticals, Inc.You BSPM | $0M | N/A | — | -$2.48 |
 Biocept, Inc. BIOCQ | $0M | N/A | — | -$56.78 |
 Clever Leaves Holdings Inc. CLVR | $0M | N/A | — | -$11.42 |
 BC Craft Supply Co. Ltd. CRFTF | $0M | N/A | — | -$0.96 |
 Plant-Based Investment Corp. CWWBF | $0M | N/A | — | -$0.23 |
 Eloxx Pharmaceuticals, Inc. ELOX | $47M | N/A | — | -$5.34 |
 HTG Molecular Diagnostics, Inc. HTGMQ | $0M | N/A | — | -$24.28 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2016-12-31Latest FY2016 | — | $-2.48 | — | |
2015-12-31 FY2015 | — | $-11.36 | — | |
2014-12-31 FY2014 | 3.50x | $2.34 | -88.1% | |
2013-12-31 FY2013 | 29.44x | $0.49 | — | |
2012-12-31 FY2012 | — | $-14.63 | — | |
2011-12-31 FY2011 | 1.42x | $9.17 | -66.8% | |
2010-12-31 FY2010 | 4.28x | $13.85 | -56.6% | |
2009-12-31 FY2009 | 9.85x | $9.48 | -75.9% | |
2008-12-31 FY2008 | 40.95x | $6.28 | -34.5% | |
2007-12-31 FY2007 | 62.49x | $4.12 | -56.4% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Biostar Pharmaceuticals, Inc. (BSPM) measures how much investors pay for each dollar of the company's trailing earnings. BSPM's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$2.48.
Frequently asked questions
BSPM pe ratio · 6 questionsBSPM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$2.48. Data sourced from Financial Modeling Prep via BSPM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biostar Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09